MACKANESS JAMES H (Chief Financial Officer) sold 6.3% of their position (8.08K shares) of SOLENO THERAPEUTICS INC on the open market
Open‑market sale worth $399.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/3/2024ACC: 0001415889-24-024664
Officer· Chief Financial Officer
Since Nov 2019
-8.08K
Net shares
Net seller
$399.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
8.08K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−7.25K
Price / share
$49.34
Trade value
$357.59K
% of position
5.7%
10/1/2024
127.25K→120K
Common Stock
Direct
Shares
−829.00
Price / share
$50.25
Trade value
$41.66K
% of position
0.7%
10/1/2024
120K→119.17K
Total
Net shares
−8.08K
Net value
-$399.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/1/2024 | S · Sale | −7.25K | $49.34 | $357.59K | 5.7% | 127.25K | 120K |
| Common Stock Direct | 10/1/2024 | S · Sale | −829.00 | $50.25 | $41.66K | 0.7% | 120K | 119.17K |
| Total | −8.08K | -$399.24K | ||||||
Derivative Transactions0
No derivative transactions reported